Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(186)
•••
Comment by robertshawon Jul 12, 2019 1:46am
105 Views
Post# 29911645

RE:RE:RE:RE:RE:Someone wants out - Good Story

RE:RE:RE:RE:RE:Someone wants out - Good Story
DeathxRay wrote:
Oilminerdeluxe wrote: And where do you think valuation will be if Ph2 results are as good as in Ph1?? LOL. A hint. Much, much higher. 


Oilminer I hope you're right.

Things just seem weird to me. 100 mil up, 100 mil down, 100 mil up, 100 mil down and then anounce a large financing the day before the AGM with no price. It's as if we are fighting a Godzilla behind the curtains.

I hope at least we can get some funds for a start, get a few good results and hopefully the trajectory will finally be going up.

Best cancer killer ever!

How are we getting no love?


yes, best cancer killer ever... But controlled by pimp or prostitute management.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities